These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27742559)

  • 41. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
    Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations.
    Leinders SM; Breedveld S; Méndez Romero A; Schaart D; Seppenwoolde Y; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1016-21. PubMed ID: 24071500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
    Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy.
    van de Schoot AJAJ; de Boer P; Visser J; Stalpers LJA; Rasch CRN; Bel A
    Acta Oncol; 2017 May; 56(5):667-674. PubMed ID: 28447562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interfractional target variations for partial breast irradiation.
    Ahunbay EE; Robbins J; Christian R; Godley A; White J; Li XA
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1594-604. PubMed ID: 21570200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.
    Hild S; Graeff C; Rucinski A; Zink K; Habl G; Durante M; Herfarth K; Bert C
    Strahlenther Onkol; 2016 Feb; 192(2):118-26. PubMed ID: 26614393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correction for 'artificial' electron disequilibrium due to cone-beam CT density errors: implications for on-line adaptive stereotactic body radiation therapy of lung.
    Disher B; Hajdok G; Wang A; Craig J; Gaede S; Battista JJ
    Phys Med Biol; 2013 Jun; 58(12):4157-74. PubMed ID: 23689060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT.
    Tian Y; Wang Z; Ge H; Zhang T; Cai J; Kelsey C; Yoo D; Yin FF
    Med Phys; 2012 May; 39(5):2754-60. PubMed ID: 22559646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications.
    Ahn PH; Chen CC; Ahn AI; Hong L; Scripes PG; Shen J; Lee CC; Miller E; Kalnicki S; Garg MK
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):677-85. PubMed ID: 20619553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
    Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
    Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
    Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients.
    Nyeng TB; Nordsmark M; Hoffmann L
    Acta Oncol; 2015; 54(9):1467-73. PubMed ID: 26223492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
    Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
    Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography.
    Harsolia A; Hugo GD; Kestin LL; Grills IS; Yan D
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):582-9. PubMed ID: 18207034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer.
    van de Schoot AJ; de Boer P; Crama KF; Visser J; Stalpers LJ; Rasch CR; Bel A
    Acta Oncol; 2016 Jul; 55(7):892-9. PubMed ID: 26934821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
    Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
    Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
    Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
    Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.